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Pre-mRNA splicing requires the function of a number of RNA-
dependent ATPaseshelicases, yet no three-dimensional structure
of any spliceosomal ATPaseshelicases is known. The highly con-
served DECD-box protein UAP56Sub2 is an essential splicing
factor that is also important for mRNA export. The expected
ATPasehelicase activity appears to be essential for the UAP56
Sub2 functions. Here, we show that purified human UAP56 is an
active RNA-dependent ATPase, and we also report the crystal
structures of UAP56 alone and in complex with ADP, as well as a
DECD to DEAD mutant. The structures reveal a unique spatial
arrangement of the two conserved helicase domains, and ADP-
binding induces significant conformational changes of key residues
in the ATP-binding pocket. Our structural analyses suggest a
specific protein-RNA displacement model of UAP56Sub2. The
detailed structural information provides important mechanistic
insights into the splicing function of UAP56Sub2. The structures
also will be useful for the analysis of other spliceosomal DExD-box
ATPaseshelicases.
helicase  RNA processing  export  crystallography
The spliceosome is a complex molecular machine responsiblefor the removal of noncoding introns and the joining of
exons. Pre-mRNA splicing also plays important roles in subse-
quent cellular processes such as mRNA export, translation, and
mRNA degradation by altering the composition of ribonucleo-
protein complexes assembled on spliced mRNAs (1, 2). A
number of ATP-using enzymes containing the characteristic
DExD sequence motif are required for the assembly, remodel-
ing, and disassembly of the spliceosome (3, 4).
Human UAP56 (56-kDa U2AF-associated protein) and its
yeast homolog Sub2 are essential DECD-box splicing factors
(5–8). UAP56 is required for the association of U2 small nuclear
ribonucleoprotein with pre-mRNA (5), and Sub2 has been
implicated in both ATP-independent and -dependent steps of
prespliceosome assembly (6, 7). Interestingly, deletion of Mud2,
the yeast homolog of U2AF65, can bypass the requirement of
Sub2 (6). It has been proposed that splicing may occur through
Sub2–Mud2 dependent and Sub2–Mud2 independent pathways.
A possible function of Sub2 is to displace Mud2 andor SF1, a
branchpoint binding protein, from pre-mRNA before the bind-
ing of U2 small nuclear ribonucleoprotein. The functions of Sub2
require intact ATPasehelicase motifs, suggesting that ATP
hydrolysis is essential for its activities (8).
UAP56Sub2 also plays important roles in the export of
mRNA from the nucleus to the cytoplasm (9–12). Reduction of
cellular UAP56 levels by RNA interference in Drosophila or
Caenorhabditis elegans resulted in the retention of significant
fractions of mRNAs in the nucleus (13–15). UAP56Sub2
couples transcription to mRNA export in the context of a
transcription–export (TREX) complex, which is recruited to
activated genes and travels the entire length of the gene with
RNA polymerase II during transcription (16).
Here, we report the crystal structures of UAP56 alone and in
complex with ADP as well as the structure of a DECD to DEAD
mutant in motif II. The structures provide mechanistic insights
into the domain organization, ADP binding, and ATP hydrolysis
of UAP56. It also allows us to propose a specific RNA-
dependent ‘‘unwindase’’ model that UAP56Sub2 may use in
pre-mRNA splicing (17, 18). The UAP56 structure also contrib-
utes to the understanding of RNA-dependent ATPasehelicases
in general, because to date only two bona fide RNA-dependent
ATPasehelicase structures have been determined (19–21),
neither of which is involved in pre-mRNA splicing or mRNA
export.
Materials and Methods
Protein Preparations. cDNA fragments encoding the full-length,
UAP56N (amino acids 44–428) and a C198A mutant were
generated by PCR and cloned into a pGEX vector. GST-fused
recombinant proteins were expressed in Escherichia coli at 17°C
and first purified on a glutathione-Sepharose column, followed
by in-column cleavage of the GST tag with thrombin. The
proteins were purified further by using a HighTrap Q Sepharose
column and a Superdex-75 gel-filtration column (Amersham
Pharmacia Biotech). Purified protein was concentrated to 20
mgml in a buffer containing 10 mM Hepes (pH 8.0), 100 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 5% glycerol, and 0.2%
2-mercaptoethanol. The stable UAP56N fragment was iden-
tified by limited proteolysis of the full-length protein with trypsin
or elastase. A time course with an 1:100 (wtwt) protease-to-
UAP56 ratio revealed stable fragments of 40 kDa. Protein
sequencing reveals that trypsin removes 35 residues and elastase
removes 42 amino acids at the N terminus.
ATPase Assay. The ATPase activity was monitored by using a
colorimetric assay based on malachite green–molybdate as de-
scribed in ref. 22, with minor modifications. The reaction buffer
contained 50 mM potassium acetate, 50 mM Hepes (pH 6.5), 2
mMmagnesium acetate, 2 mMdithiotreitol, and 0.1mgml BSA.
Reactions were incubated at 37°C in a 25-l volume for 40 min
and stopped with the addition of 5 l of EDTA. The optimum
conditions for the activity were at pH 5.5–6.5 and 2 mM
magnesium concentration. The ATPase activity was 30%
lower at conditions with pH 6.5 or magnesium concentrations
2 mM. For reactions with varying protein concentrations, 1
mM ATP (Amersham Pharmacia Biotech) and 400 ngl yeast
RNA (Type III, Sigma) were used. Protein was incubated with
RNA before adding ATP. For reactions with varying RNA
concentrations, different amounts of RNA were added to the
reactionmixture together with 300 ngl protein, followed by the
addition of 1 mM ATP to start the reaction. Curve fits were
Abbreviations: PDB, Protein Data Bank; SF2, superfamily II.
Data deposition: Atomic coordinates and structure factors have been deposited in the
Protein Data Bank, www.pdb.org [PDB ID codes 1XTI (UAP56N), 1XTJ (MgADP complex),
and 1XTK (DEAD mutant)].
§To whom correspondence should be addressed. E-mail: xur@cshl.org.
© 2004 by The National Academy of Sciences of the USA
17628–17633  PNAS  December 21, 2004  vol. 101  no. 51 www.pnas.orgcgidoi10.1073pnas.0408172101
obtained by using the GOGRAPH PRISM 4 (www.graphpad.com)
software from three independent reactions.
Crystallographic Methods. UAP56N was crystallized by hanging
drop vapor diffusion in a condition containing 100 mM Hepes
(pH 7.5), 5% isopropanol, and 3% 2-mercaptoethanol. Macro-
seeding improved the crystal size. The C198A mutant was
crystallized under the same condition. The UAP56N–MgADP
complex was crystallized in the presence of 2 mM ADP and in
a condition containing 50 mM ammonium acetate, 10 mM
MgCl2, 50 mMTris (pH 7.5), and 10% 2-methyl-2,4-pentanediol.
All diffraction data were collected at 100 K by using a charge-
coupled device detector (Area Detector Systems, Poway, CA) at
the X26C and X12C beamlines of the National Synchrotron
Light Source (Brookhaven National Laboratory, Upton, NY).
All data were processed by using HKL (23), and statistics are
shown in Table 1.
The structure of UAP56N was solved by molecular replace-
ment with AMORE (24), by using the polyalanine models derived
from the N- and C-terminal domains of yeast eIF4A [Protein
Data Bank (PDB) ID codes 1FUK and 1QDE]. Refinement was
carried out by using CNS (25). The graphics program O (26) was
used for model building, structural alignment, and modeling.
UAP56N (C198A) and UAP56N–MgADP structures were
solved by molecular replacement with the UAP56N structure
as the search model. Refinement statistics are shown in Table 1.
Figures were prepared with the programs MOLSCRIPT (27),
RASTER3D (28), GRASP (29), and PYMOL (30).
Results and Discussion
Conservation and RNA-Dependent ATPase Activity. Human UAP56
has 428 aa, and it shares 62% sequence identity and 78%
similarity with its yeast counterpart, Sub2 (Fig. 1A). The first
40 residues of UAP56 are not highly conserved between
UAP56 and Sub2. Limited proteolytic digestion of purified
UAP56 with elastase removed N-terminal 42 residues (data not
shown). A UAP56 fragment lacking 43 residues at the N
terminus, UAP56N, was used for structural studies here. As
shown in Fig. 1A, UAP56N contains all of the conserved
sequence motifs common to the DExDH family of ATPases
helicases (31), as well as the recently identified Q motif specific
to the DEAD subfamily (22).
The ATPasehelicase activities of UAP56 or its homologs had
not been demonstrated before this study. Here, we show that the
full-length UAP56 and UAP56N are active, albeit weak,
RNA-dependent ATPases in vitro (Fig. 1 B and C). In the
absence of RNA, both UAP56 and UAP56N had negligible
ATPase activities (Fig. 1B). The ATPase activities were stimu-
lated greatly with the addition of total yeast RNAs (Fig. 1 B and
C). UAP56N has a reduced activity compared with that of the
full-length, wild-type protein (50%). AC198Amutation, which
changes the DECD box to a DEAD box, both in the context of
full-length UAP56 and in UAP56N, did not significantly
change the ATPase activities in our assay (Fig. 1 B and C).
Overall Structure. The apo-UAP56N structure was solved by
molecular replacement using polyalanine models derived from
the N- and C-terminal domain structures of yeast eIF4A (19).
The refined 1.95-ÅUAP56N structure has anR factor of 21.8%
and Rfree of 25.8%. The structure also has good stereochemical
properties, with 89.4% of the residues in the most favored region
of the Ramachandran plot, calculated with PROCHECK (32).
Detailed statistics of the crystallographic analyses are shown in
Table 1.
UAP56N comprises two canonical, RecA-like  helicase
domains (33) (Fig. 2A). The N-terminal domain contains a
seven-stranded parallel -sheet in the spatial order of 7–1–
6–5–2–4–3. Eight -helices packed against the -sheet on
both sides as follows: A, B, C, and D on one side, and E,
F,  G, and H on the other side (Fig. 2A). The nomenclature
for secondary structure elements is defined in Fig. 1A. The
C-terminal domain also contains seven parallel -strands, form-
ing a twisted -sheet in the spatial order of 10–11–9–12–
13–8–14. There are five helices in the C-terminal domain as
follows: I and J on one side of the -sheet, and K, L, and
M on the opposite side. The overall folds of the N- and
C-terminal domains resemble that of other superfamily II (SF2)
ATPaseshelicases (34).
A structure-homology search on the Dali server (www.ebi.
ac.uk/dali) revealed that the closest matches to the N- and
Table 1. Summary of crystallographic analysis
Data sets UAP56N UAP56N-ADP UAP56N (C198A)
Spacegroup P1 P21 P1
Cell dimensions, Å 37.16  49.91  62.27 37.00  78.09  63.19 37.43  49.76  62.81
Cell angles, ° 95.7  101.6  111.1 90  103.4  90 95.6  101.9  110.9
No. of proteins per asu,* Vm 1 (2.33 Å3Da) 1 (1.98 Å3Da) 1 (2.36 Å3Da)
Resolution, Å 1.95 2.7 2.4
Measured reflections 107,519 27,997 55,301
Unique reflections 28,304 9,164 14,805
Average I 19.7 15.0 20.9
Completeness, % (I  0) 96.1 (87.3) 94.6 (89.1) 92.9 (75.6)
Rmerge,† % 4.0 (18.0) 8.5 (14.1) 6.0 (10.1)
Refinement
Resolution range, Å 50.0–1.95 50.0–2.8 50.0–2.4
R factorRfree,‡ % 21.825.8 2130 24.329.8
No. of protein atoms 3,089 3,017 (1 MgADP) 3,095
No. of solvent molecules 4 isopropanol, 245 water 1 acetate, 85 water 1 BME, 59 water
rms deviations
Bond lengths, Å 0.008 0.007 0.008
Bond angles, ° 1.22 1.35 1.31
*asu, asymmetric unit; Vm, Matthews coefficient.
†RmergeI I	I	, where I and I	 are the measured and averaged intensities of multiple measurements of the same reflection. The
sum is over all the observed reflections.
‡R factor  Fo Fo Fo, where Fo denotes the observed structure factor amplitude and FC denotes the structure factor calculated
from the model.
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C-terminal domains of UAP56N are the corresponding do-
mains of an archaeal DEAD-box protein mjDEAD (35), the
yeast translation initiation protein eIF4A (19, 36, 37), and a
prokaryotic nucleotide excision repair helicase UvrB (38–40).
The N-terminal domain of UAP56N can be superimposed with
the corresponding domain of mjDEAD (PDB ID code 1HV8; Z
score 30.9), eIF4A (PDB ID code 1QVA; Z score 30.5), and
UvrB (PDB ID code 1D2M; Z score 12.8) with rms deviations
of 1.4, 1.6, and 3.0 Å, respectively. The rms deviations between
the C-terminal domain of UAP56N and that of eIF4A (PDB ID
code 1FUK; Z score  21.2), mjDEAD (Z score  18.8), and
UvrB (Z score  13.1) are 2.0, 2.1, and 2.7 Å, respectively.
The two domains are joined covalently by a nine-residue
interdomain linker (Fig. 2A). Besides the linker, the two domains
contact each other mainly by means of a portion of K in the
C-terminal domain and A and D in the N-terminal domain
(Fig. 2). The ‘‘open’’ conformation of the two domains creates
a large pocket between them. Amino acids belonging to the
conserved ATPasehelicase motifs are located either inside or
on the protein surface adjacent to the pocket (Fig. 2A). The
location of these conserved residues suggests that ATP binds in
the pocket between the two domains.
ATP-Binding Pocket and UAP56–ADP Interactions.To understand the
exact mode of UAP56–ATP interaction and the mechanism of
ATP hydrolysis, we attempted but failed to cocrystallize
UAP56N with ATP or its nonhydrolyzable analogs (adenosine
5
-[,-imido]triphosphate or adenosine 5
-[-thio]triphos-
phate). Soaking the apo-UAP56N crystals with ATP or its
nonhydrolyzable analogs resulted in rapid dissolving of
UAP56N crystals. We cocrystallized UAP56N with MgADP
and solved a 2.7-Å structure by molecular replacement. A
Fig. 1. Sequence conservation and ATPase activity of UAP56. (A) Alignment of human UAP56, yeast Sub2, and eIF4A sequences (white over blue, identical; black
over yellow, similar). Conserved sequence motifs are enclosed in red rectangles. (B) ATPase activities of wild-type (WT) and variant UAP56 proteins. ATPase
activities were not detectable without total yeast RNA (No RNA). With 0.4 gl total yeast RNA, both the WT and a DEAD mutant exhibited concentration-
dependent ATPase activities. UAP56N (N) and its DEAD mutant (N-DEAD) have reduced activities. (C) RNA concentration dependence of UAP56 ATPase
activities. A fixed protein concentration (0.3 gl) was used in the assays.
Fig. 2. Overall structure. The structure of UAP56N is shown as a ribbon
model (A) and in a surface representation (B), viewed from a similar direction.
(A) Cyan, N-terminal domain; brown, C-terminal domain; green, interdomain
linker. Locations of conserved helicase sequence motifs are labeled. (B) Blue,
positively charged electrostatic potential; white, neutral electrostatic poten-
tial; red, negatively charged electrostatic potential. A large ATP-binding cleft
is formed between the N- and C-terminal helicase domains.
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difference electron density map clearly shows the presence of an
ADP molecule and a magnesium ion (Fig. 3A). The two helicase
domains in the complex structure adopt an interdomain confor-
mation very similar to that in the apostructure, although
UAP56N and the UAP56N–MgADP complex were crystal-
lized under different conditions and belong to different space-
groups (P1 vs. P21). In the complex structure, residues 347–351,
which are parts of motif V, and five residues at the C terminus
(amino acids 424–428) are disordered.
As expected, ADP is bound in the pocket between the N- and
C-terminal domains. The adenine base is bound in a region
formed by a loop encompassing residues 65–69 (Phe-65, Glu-66,
His-67, Pro-68, and Ser-69) and residues Phe-47, Gln-72, and
Ala-97. In particular, the N6 atom of the adenine ring forms a
hydrogen bond with the carbonyl group of His-67, and the N6
and N7 atoms of the base also interact with the O1 and N2
atoms of Gln-72 (from the Q-motif), respectively (Fig. 3A).
Additionally, the adenine ring stacks with the phenyl ring of
Phe-65. The side chains of Phe-65 and Gln-72 appear to be the
major determinants of ADP binding, because other residues,
such as Phe-47 and Ala-97, contact the base through van der
Waals interactions.
The ribose moiety is bound in a manner with the 2
 and 3

hydroxyl groups pointing away from the N-terminal domain. The
pyrophosphate moiety makes extensive interactions with resi-
dues in Motif I (Fig. 3A). The  phosphate of ADP directly
interacts with the conserved Thr-96 by means of a hydrogen
bond (Fig. 3A). The oxygen atoms of the  phosphate make three
hydrogen bonds with the backbone amide groups of Gly-92,
Gly-94, and Lys-95, the latter two residues being part of the
invariant GKT triplet of motif I. The O2 atom of the  phosphate
makes an additional hydrogen bond to the N atom of Lys-95.
The O3 atom interacts with a magnesium ion, which is coordi-
nated by Glu-197 (2.7 Å apart). Although the magnesium ion is
further away from Asp-196 (3.5 Å apart), the presence of this
negatively charged residue contributes to the binding of the
magnesium ion.
The binding of MgADP induces structural rearrangement
near the pyrophosphate moiety and the magnesium binding site.
Upon ADP binding, the motif I loop (amino acids 90–94)
undergoes significant conformational changes, moving in a
direction away from the center of the N-terminal domain (Fig.
3B). This conformational change is necessary to accommodate
the binding of ADP, because the pyrophosphate moiety is
inserted between the motif I loop and the body of the N-terminal
domain. The side chains of several invariant residues surround-
ing ADP, notably Lys-95 and Glu-197, undergo large conforma-
tional changes to accommodate the binding of MgADP (Fig.
3B). In the absence of MgADP, Lys-95 contacts Asp-196 by
means of ionichydrogen bond interactions. The binding of
MgADP displaces the above interactions and gives rise to the
Mg2-Asp-196 and -phosphate-Lys-95 bondings shown in Fig.
3. Glu-197 points away from the magnesium binding site when
MgADP is not present (Fig. 3B).
A DECD to DEAD Mutant Destabilizes Motif III. UAP56 contains a
characteristic DECD box, distinct from a large number of
DEAD-box RNA helicases. Glu-197 in the DECD motif binds
the magnesium ion and can serve as the catalytic base in ATP
hydrolysis (Fig. 3A). Cys-198 and Asp-199 stabilize the SAT loop
in Motif III: Asp-199 makes several hydrogen bonds with the
backbone amide groups of the SAT loop, as well as with the
hydroxyl group of Ser-228 (Fig. 3B). Cys-198 is buried, and
the sulfhydryl group makes a hydrogen bond with the carbonyl
of Phe-147. It was reported that changing the DECD motif of
Sub2 to a more common DEADmotif renders the yeast inviable
(8). Our in vitro assay revealed that the C198A mutation of
UAP56 only has a mild effect on the RNA-stimulated ATPase
Fig. 3. MgADP binding site. (A) A stereoview of UAP56–MgADP interactions (protein is shown in a ribbon representation; ADP and residues contacting MgADP
are shown in stick models; and magnesium ion is depicted as a green sphere). An omit difference (MgADP is omitted) electron density map is shown at 3.0 cutoff
level. Red dashed lines denote hydrogen bonds or ionic bonds when the magnesium ion is involved. (B) Superposition of apo- and MgADP-bound structures.
White ribbons represent the apostructure of UAP56; salmon-colored ribbons represent the MgADP-bound UAP56. ADP and selected residues are shown in a stick
representation. Residues from the apostructure are colored white.
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activity (Fig. 1 B and C). It is possible that the C198A mutation
induces structural changes distant from the ATPase catalytic
site, thus interfering with other functions of UAP56. To learn the
potential structural changes, we crystallized the DEAD variant
of UAP56N under the same condition in which the apoform of
UAP56N crystals was obtained. The mutant and the wild-type
structures were virtually identical, except that the helix (H)
immediately following the SAT motif (motif III) has poor
electron density (data not shown), suggesting that the helix is
destabilized in the mutant structure. Motif III differs both in
length and amino acid composition among various helicases, and
a consensus function of this motif is not clear. In PcrA (41), this
motif has been implicated in interdomain interactions. In hep-
atitis C virus NS3 (19–21, 42), UvrB (38–40), and SecA (43),
motif III is involved in interacting with the protein-specific extra
domains that form part of the ligand-binding site. Because H
is located on the surface and exposes a large accessible area (see
Fig. 5A), it is likely that it is involved in interacting with RNA or
other protein factors.
Structural Comparison. The overall fold of UAP56 domains is very
similar to that of all other SF2 helicases, including the recently
determined separate domain structures of UAP56 (44). The N-
and C-terminal domain structures in this study (the apoform)
superimpose with the corresponding domains in ref. 44 at rms
deviations of 1.14 and 2.1 Å, respectively. The main differences
in the N-terminal domain are as follows: (i) the citrate-bound
motif-I loop in ref. 44 resembles the ADP-bound conformation
in our structure; and (ii) the helix H (motif III) is shifted by
2.1–4.2 Å between the structures of apo-UAP56N and that
of ref. 44. The structural f lexibility of H is consistent with our
observation that this helix is partially destabilized in the C198A
mutant. Our structure, which contains both domains, does not
support the proposal that the N-terminal domain of UAP56
forms a dimer (44). The two C-terminal domains superimpose
with an rms deviation of 2.1 Å. Substantial conformational
differences occur in two segments spatially close to each other,
i.e., residues 346–355 (motif V) and 378–383 (motif VI). This
region is stabilized by crystal packing in the C-terminal domain
structure in ref. 44, and this region is f lexible in our structure
with the two domains together. As described earlier, the motif V
loop is disordered in the structure of the UAP56N–MgADP
complex. All together, the structural differences suggest that
motifs III, V, and VI are likely to be dynamic in solution.
The most striking difference among the SF2 helicases is the
spatial organization of the two helicase domains. Among the SF2
structures, only two are well documented DExDH box RNA-
dependent ATPaseshelicases. They are the hepatitis C virus
NS3 RNA helicase domain (20, 21) and yeast eIF4A (19).
UAP56, eIF4A, NS3, andmjDEAD all have distinct interdomain
conformation (Fig. 4): the two eIF4A domains are not in contact
(Fig. 4A), and the two domains in NS3 and UvrB are closer to
each other (a ‘‘closed’’ conformation). When the two N-terminal
domains are superimposed, the C-terminal domain of NS3 is
rotated 71° with respect to the C-terminal domain of UAP56
(Fig. 4B), whereas the corresponding rotation involving UvrB is
79° (data not shown). The two mjDEAD domains are in an
intermediate conformation, with an 50° rotation between the
Fig. 5. A model of UAP56 mechanisms. (A) The branch point-containing RNA
in the SF1–RNA complex is modeled into the putative RNA-binding channel of
UAP56. The main chain of SF1 is shown as a cyan worm model, and the RNA is
shown in a stick model. The exposed surface area of motif III, which is partially
destabilized in the DEAD mutant, is colored green. (B) A ‘‘spring-loaded’’
unwindaseATPase model of UAP56. Steps i and iv represent initial (apo) and
product-bound (MgADP) conformation. In the presence of ATP, interactions
with an RNA-bound U2AF65 or SF1 are likely to cause a reposition of the two
helicase domains resembling the ‘‘productive’’ ATPase conformation (ii) as in
UvrB. The RNA (shown in magenta) is sandwiched between the two proteins.
Because both RNA and the RNA-binding protein (shown in green) contact
both helicase domains, the large domain movement accompanying ATP hy-
drolysis rips attached RNA from the RNA-binding protein (iii).
Fig. 4. Domain organizations. (A) The UAP56 structure (cyan) is superimposed with the structures of yeast eIF4A (red; PDB ID code 1FUU) and mjDEAD (yellow;
PDB ID code 1HV8). The N-terminal domains were aligned. The dashed magenta line indicates the axis around which a rotation of 50° will superimpose the
C-terminal domain of UAP56 with that of mjDEAD. (B) Superposition of UAP56 with hepatitis C virus helicase (PDB ID code 1A1V) (helicase domains shown in
green; extra domain shown in magenta and beige), viewed from a perpendicular direction (from left to right) with respect to that in A. The magenta dashed
arc indicates a rotation of 71° between the two C-terminal domains. The single-stranded DNA oligo bound to the viral helicase is shown in a stick model.
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two C-terminal domains when UAP56N and mjDEAD are
superimposed through the N-terminal domains (Fig. 4A). The
rotation is around an axis approximately passing through the C
atoms of Thr-344 and Gln-337 of UAP56 (Fig. 4A). The open
conformation of UAP56 is likely to represent the apoconfor-
mation and a product-bound conformation, whereas a closed
conformation similar to that of UvrB resembles that of a
productive ATPase, because the two domains need to be in
contact during ATP hydrolysis.
Structural Implications. UAP56, eIF4A and mjDEAD have distinct
domain organizations, and they all comprise only the two essential
helicase domains. Other SF2 family members, such as UvrB, NS3,
PcrA, Rep, and SecA, contain extra nonconserved domains. The
two helicase domains in the proteins with the extra domains have
more stable and similar spatial organizations. These proteins with
extra domains also have more robust and processive ATPase
helicase activities in the absence of other protein factors. In all
cocrystal structures of SF2 helicases solved to date, namely NS3
(21), PcrA (41), and Rep (45), single-stranded DNA is bound in a
cleft between the helicase domains and the extra nonconserved
domains. In addition, the equivalent site has been proposed to be
a protein-binding site in SecA (43). Thus, it appears that a con-
served ligand-binding site in the SF2 family of helicases is located
at the interface between the helicase domains and separate, pro-
tein-specific domains. UAP56, eIF4A, and mjDEAD lack extra
domains, so it is likely that the equivalent roles of the extra domains
are provided by their respective interacting proteins. The relatively
low ATPase activities of UAP56 may be due to the absence of
suitable substrates, possibly including both RNA and protein fac-
tors; two candidate proteins are U2AF65 and SF1.
We explored this hypothesis further by molecular modeling.
Because no structure of an RNA-bound U2AF65 has been deter-
mined, we examined the possibility with SF1 by using the NMR
structure of the SF1 RNA-binding domain complexed with a
branch point-containing RNA (46). Although SF1 is not known to
stably interact with UAP56, they are in close proximity because
both proteins can interact simultaneously with U2AF65 (8, 46). As
shown in Fig. 5A, the RNA in the SF1 complex fits well in the
putative RNA-binding cleft of a modeled UAP56 structure, with
the two domains in a conformation similar to that of UvrB andNS3
(Fig. 4B). The exposed RNA backbone faces UAP56, similar to the
situation in the NS3–ssDNA complex (21). In this model, only one
loop in SF1 (amino acids 188–192) clashes with UAP56. However,
this loop is one of the most flexible regions in the NMR structure
(46), suggesting that it is capable of undergoing large conforma-
tional changes (the averaged NMR structure is used for modeling
here), thus the clashes may be avoided when the loop takes an
alternate conformation. It is interesting to note that the SF1 domain
also contacts both domains in UAP56, and the interaction area in
UAP56 is near the exposed surface of H (Fig. 5A), which is
destabilized in the C198Amutant structure. Upon ATP hydrolysis,
the two domains of UAP56 return to the product-bound confor-
mation as observed in the crystal structures. Because the RNA
contacts both domains in UAP56, the large domain movement
accompanying ATP hydrolysis is likely to rip the RNA apart from
SF1 by stretching andor constraining the RNA structure. The
release of separated RNA and protein from UAP56 and the
exchange of ATP with the reaction product ADP should prepare
UAP56 for the next round of reaction. A schematic drawing of the
proposed model is shown in Fig. 5B.
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